Trial | NCT02029625  Report issue

Title

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    41
The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.
rosuvastatin and ezetimibe(anti-dyslipidemia)
Study Started
Feb 28
2014
Primary Completion
Mar 31
2014
Study Completion
Mar 31
2014
Last Update
Mar 25
2016
Estimate

Drug NVP-1205

rosuvastatin/ezetimibe fixed dose combination orally, once daily on Period 1 or Period 2

  • Other names: NVP-1205(rosuvastatin+ezetimibe)

Drug rosuvastatin and ezetimibe

coadministration of rosuvastatin and ezetimibe orally, once daily on Period 1 or Period 2

  • Other names: Crestor and Ezetrol

NVP-1205 Experimental

administration of NVP-1205(rosuvastatin+ezetimibe)

rosuvastatin and ezetimibe Active Comparator

coadministration of rosuvastatin and ezetimibe

Criteria 

Inclusion Criteria:

Healthy male subjects age between 19 and 55 signed informed consent

Exclusion Criteria:

subjects have a history of allergy reaction of this drug or other drugs
No Results Posted